Ellevest Inc’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-24
Closed -$2K 1619
2021
Q2
$2K Buy
+24
New +$2.34K ﹤0.01% 1093
2020
Q2
Hold
0
1378
2020
Q1
Hold
0
1340

Other funds holding VBIV

Ellevest Inc's VBIV Position: Q3 2021 in Review

Ellevest Inc sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2021, closing a stake of 24 shares — an estimated $2K sold.

Ellevest Inc first reported a position in VBIV in Q2 2021 and held it in 1 quarter. The position peaked at $2K in Q2 2021. 126 funds tracked by Wall St. Rank hold VBIV as of Q3 2021.

  • Ellevest Inc reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2021 after selling out during the quarter.
  • Ellevest Inc sold 24 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2021, an estimated $2K.
  • Ellevest Inc first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2021 and held it in 1 quarter.
  • Ellevest Inc's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $2K in Q2 2021.
  • 126 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2021.

Based on Ellevest Inc's 13F filing for Q3 2021, filed 19 Oct 2021.